SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001980840-24-000001
Filing Date
2024-11-13
Accepted
2024-11-13 07:55:51
Documents
1

Document Format Files

Seq Description Document Type Size
1 13G INITIAL mruckBCLI1112.htm SC 13G 25697
  Complete submission text file 0001980840-24-000001.txt   27401
Mailing Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019
Business Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019 201-488-0460
BRAINSTORM CELL THERAPEUTICS INC. (Subject) CIK: 0001137883 (see all company filings)

IRS No.: 207273918 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-79890 | Film No.: 241451238
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 9711 WASHINGTONIAN BLVD SUITE 550 GAITHERSBURG MD 20878
Business Address
Ruck Matthew J (Filed by) CIK: 0001980840 (see all company filings)

Type: SC 13G